
MStranslate
@MStranslate
Followers
5K
Following
895
Media
824
Statuses
4K
Providing accurate, unbiased, easy to understand information about multiple sclerosis research and news worldwide. #MultipleSclerosis #MS
Melbourne, Australia
Joined September 2012
Research has found there are many benefits to people living with #MultipleSclerosis maintaining their employment after diagnosis. However, a @LancasterUni study shows the support & understanding needed to ensure this happens isn't always available. #MS
lancaster.ac.uk
New research by the Work Foundation at Lancaster University and the MS Society exploring the employment experiences of people with multiple sclerosis (MS). The report highlights the enablers and...
0
0
0
We’re proud to be involved in Patient Community Day at @ECTRIMS! This event communicates the most important findings in #MultipleSclerosis research to the people most impacted by them, direct from the world’s largest #MS conference. Register for free now:
ectrimspatientcommunity.eu
Every year, the ECTRIMS Annual Congress showcases the most groundbreaking and care-advancing MS research from around the world. Join our community today.
0
0
2
This @Cambridge_Uni study, while at a very early stage, has identified a promising new approach for myelin repair in people living with #MultipleSclerosis. #MS [2/2].
0
0
0
“This research provides critical evidence that induced neural stem cell grafts can effectively turn into myelin-producing cells within the damaged central nervous system, suggesting a potential new way to treat progressive MS" - Dr Peruzzotti-Jametti [1/2]
neuroscience.cam.ac.uk
Multiple sclerosis (MS) is an autoimmune disease where the body’s immune system mistakenly attacks the central nervous system, leading to the destruction of myelin, the protective sheath surrounding…
1
4
12
Many people living with #MultipleSclerosis use #cannabis to help manage symptoms, such as spasticity & pain. However, recent research from @UofT has found that the use of cannabis may significantly worsen cognition in people living with #MS. [1/2]
2
1
4
Although in a very early stage of the research process, this new study from scientists at @nyulangone has the potential to provide a completely novel approach to treating autoimmune diseases, such as #MultipleSclerosis. #MS
0
0
3
Sleep disturbances are common in people living with #MultipleSclerosis & often lead to a worsening of many other symptoms. Research has shown there are potential pharmacological & non-pharmacological approaches that can help treat this problem. #MS [1/2]
3
2
8
Do you want to hear about the latest research into biomarkers in #MultipleSclerosis? If so, the latest edition of The @ECTRIMS Podcast is for you! #MS #Podcasts
ectrims.eu
Biomarkers are one of the most exciting and fast-evolving areas in multiple sclerosis research, offering promise for earlier diagnosis, accurate prognosis, and truly personalised treatment. Yet...
0
0
8
While more information is needed to completely understand & confirm this finding, it suggests that men with #MS taking androgen modifying therapies should be monitored closely for disease worsening. [2/2].
0
0
0
A small study by researchers at the @MayoClinic has found that men living with #MultipleSclerosis taking hormone modifying therapies might have a higher risk of increased disease activity. [1/2]
1
0
2
We are excited to share that our co-founder, Brett Drummond, will again have the privilege of hosting & moderating the Patient Community Day at @ECTRIMS 2025. Registrations are now open. Use the link below & join him in Barcelona or online. #MultipleSclerosis #MS.
📣 Save the date! Patient Community Day is happening on 26 Sep 2025 in Barcelona and online. Join us for this FREE event filled with knowledge-sharing & support. Learn more here ➡️ . #ECTRIMS4me #MSAwareness #MSResearch
0
0
8
Heard of a pseudorelapse? It refers to a temporary worsening of symptoms caused by external factors such as infection or stress. Importantly, a pseudorelapse isn't caused by new inflammatory activity & usually improves on its own. #MultipleSclerosis #MS [1/2]
1
1
3
PIPE-307 is currently being trialled as a myelin repair therapy in people living with #MultipleSclerosis. This @UCSF article outlines how #research led to the development of this possible remyelination treatment. #MS
ucsf.edu
Scientists at UCSF and Contineum Therapeutics have developed a drug that spurs the body to replace the protective insulation around nerve cells, myelin, that is lost in multiple sclerosis. If it...
1
8
24
"It is a significant finding to see this accelerated aging in children. If we can understand the interplay between the immune system, the brain and aging…we might be able to put #MS into full remission" - Dr Jennifer Graves, @UCSanDiego #MultipleSclerosis
today.ucsd.edu
The study focused on children and teenagers not yet impacted by the processes of normal aging and age-related illnesses like hypertension and diabetes. Despite appearing outwardly healthy, children...
0
3
8
Phase 3 trials of @Roche's Bruton's tyrosine kinase inhibitor (BTKi), fenebrutinib, are currently underway. However, long-term follow-up of participants from the Phase 2 trial are showing some promising results. #MultipleSclerosis #MS
roche.com
Patients on fenebrutinib had low relapse rates with data showing no active brain lesions or disability progression after nearly two years of treatmentPhase III studies for fenebrutinib in relapsing...
0
2
9
A new @AucklandUni study has found that the rates of #MultipleSclerosis are on the rise in New Zealand. Importantly, they found this was the case across a range of ethnic backgrounds, incl. European New Zealanders, Māori, Pacific peoples & Asian groups.
0
1
4
Heard of the central vein sign (CVS) in #MultipleSclerosis? It’s a proposed biomarker, appearing on MRI, that can help with the diagnosis of #MS. While there’s more to learn, @UniofNottingham research has suggested the CVS might be as effective as a lumbar puncture for diagnosis.
0
0
1